載入...
Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
The purpose of this study was to investigate the antitumor activity of regorafenib and sorafenib in preclinical models of HCC and to assess their mechanism of action by associated changes in protein expression in a HCC-PDX mouse model. Both drugs were administered orally once daily at 10 mg/kg (rego...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5739799/ https://ncbi.nlm.nih.gov/pubmed/29291014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22334 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|